These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
12. Novel insights into the treatment of complement-mediated hemolytic anemias. Berentsen S; Hill A; Hill QA; Tvedt THA; Michel M Ther Adv Hematol; 2019; 10():2040620719873321. PubMed ID: 31523413 [TBL] [Abstract][Full Text] [Related]
13. Sutimlimab: A Complement C1s Inhibitor for the Management of Cold Agglutinin Disease-Associated Hemolysis. Moore DC; Arnall JR Ann Pharmacother; 2023 Aug; 57(8):970-977. PubMed ID: 36476151 [TBL] [Abstract][Full Text] [Related]
14. New Insights in Autoimmune Hemolytic Anemia: From Pathogenesis to Therapy Stage 1. Barcellini W; Zaninoni A; Giannotta JA; Fattizzo B J Clin Med; 2020 Nov; 9(12):. PubMed ID: 33261023 [TBL] [Abstract][Full Text] [Related]
15. New Insights in the Pathogenesis and Therapy of Cold Agglutinin-Mediated Autoimmune Hemolytic Anemia. Berentsen S Front Immunol; 2020; 11():590. PubMed ID: 32318071 [TBL] [Abstract][Full Text] [Related]
16. Inhibition of complement C1s in patients with cold agglutinin disease: lessons learned from a named patient program. Gelbenegger G; Schoergenhofer C; Derhaschnig U; Buchtele N; Sillaber C; Fillitz M; Schenk TM; D'Sa S; Cartwright R; Gilbert JC; Jilma B; Jaeger U Blood Adv; 2020 Mar; 4(6):997-1005. PubMed ID: 32176765 [TBL] [Abstract][Full Text] [Related]
17. The evolving management algorithm for the patient with newly diagnosed cold agglutinin disease. Barcellini W; Fattizzo B Expert Rev Hematol; 2024 Jul; 17(7):287-294. PubMed ID: 38872338 [TBL] [Abstract][Full Text] [Related]
18. How I treat cold agglutinin disease. Berentsen S Blood; 2021 Mar; 137(10):1295-1303. PubMed ID: 33512410 [TBL] [Abstract][Full Text] [Related]
19. Inhibition of complement C1s improves severe hemolytic anemia in cold agglutinin disease: a first-in-human trial. Jäger U; D'Sa S; Schörgenhofer C; Bartko J; Derhaschnig U; Sillaber C; Jilma-Stohlawetz P; Fillitz M; Schenk T; Patou G; Panicker S; Parry GC; Gilbert JC; Jilma B Blood; 2019 Feb; 133(9):893-901. PubMed ID: 30559259 [TBL] [Abstract][Full Text] [Related]
20. Sustained inhibition of complement C1s with sutimlimab over 2 years in patients with cold agglutinin disease. Röth A; Barcellini W; D'Sa S; Miyakawa Y; Broome CM; Michel M; Kuter DJ; Jilma B; Tvedt THA; Weitz IC; Yoo R; Jayawardene D; Vagge DS; Kralova K; Shafer F; Wardȩcki M; Lee M; Berentsen S Am J Hematol; 2023 Aug; 98(8):1246-1253. PubMed ID: 37246953 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]